Page 2101 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2101

1864   Part XII  Hemostasis and Thrombosis

        Release of Mature Platelets                           exhibit a highly disorganized DMS, and fail to generate proplatelets
                                                              in  vitro,  a  phenotype  indicative  of  a  late  block  in  megakaryocyte
        Details of how mature platelets release from the proplatelet tips are   maturation. Therefore NF-E2 appears to control the transcription of
        beginning to come into focus. In vitro, maturation of proplatelets   a limited number of genes involved in cytoplasmic maturation and
        ends  in  a  rapid  retraction  that  separates  a  variable  portion  of  the   platelet formation. Shivdasani and colleagues generated a subtracted
        proplatelets  from  the  residual  cell  body,  leaving  behind  a  naked,   cDNA  library  enriched  in  transcripts  downregulated  in  NF-E2
        denuded nucleus (see Fig. 124.5C). Activation of apoptotic pathways   knockout megakaryocytes. Using this approach, these investigators
        in the cell body has been shown to be coincident with this event.   have  started  to  identify  the  downstream  targets  of  NF-E2  and  to
        Junt and colleagues have used intravital fluorescence microscopy to   analyze their role in the terminal stages of megakaryocyte differentia-
        visualize proplatelet production in the opened cranial marrow cavity   tion. Putative transcriptional targets of NF-E2 include β 1 tubulin,
                   16
        of living mice.  Yellow fluorescent protein (YFP)–labeled megakaryo-  thromboxane synthase, and proteins that regulate inside-out signaling
        cytes were seen to protrude proplatelets and release megakaryocyte   via α IIb β 3 integrin. The zinc finger protein GATA1 is also a transcrip-
        fragments into the marrow sinusoids of living mice. Notably, these   tion factor that plays a critical role in driving the expression of genes
        anucleate fragments typically exceed platelet dimensions, suggesting   essential  for  megakaryocyte  maturation.  However,  unlike  NF-E2,
        that platelet morphogenesis continues in the circulation. In line with   which appears to drive the later stage of megakaryocyte development,
        these observations, we have recently identified a previously unrecog-  GATA1 functions at multiple stages of development. Initially, GATA
        nized intermediate stage in platelet formation and release, which we   proteins were thought to regulate red blood cell maturation because
                         17
        termed  the  preplatelet.   Preplatelets  are  defined  as  discoid  cells   genetic disruption of the GATA1 gene in mice results in embryonic
        (3–10 µm)  that  retain  the  capacity  to  convert  into  barbell-shaped   lethality  secondary  to  a  block  in  erythropoiesis.  However,  several
        proplatelets  and  undergo  fission  into  platelets.  The  conversion  of   more  recent  observations  also  implicate  GATA1  as  a  regulator  of
        preplatelets to barbell proplatelets is powered by microtubule-based   megakaryocyte differentiation. First, forced expression of GATA1 in
        forces. It is likely that the microtubule motors that drive proplatelet   the early myeloid cell line 416b induces megakaryocyte differentia-
        extension are involved in aspects of platelet release, as well as in the   tion. Second, Shivdasani and colleagues used targeted mutagenesis of
        process of microtubule coiling. Sliding of an uncoiled portion of the   regulatory elements within the GATA1 locus to generate mice with
        microtubule relative to the rigid microtubule bundle in the proplatelet   a  selective  loss  of  GATA1  in  the  megakaryocyte  lineage.  These
        tip would provide a simple mechanism to effect platelet release and   knockdown mice expressed sufficient levels of GATA1 in erythroid
        would explain the variable morphology of the small but reproducible   cells to circumvent the embryonic lethality caused by anemia. GATA1
        percentage (<5%) of dumbbell-shaped platelets that are present in   deficiency  in  megakaryocytes  leads  to  severe  thrombocytopenia.
        blood. Recently, it was demonstrated that individual human platelets   Platelet counts are reduced to approximately 15% of normal, and the
        have the innate capacity to duplicate and form new cell bodies that   small  numbers  of  circulating  platelets  are  round  and  larger  than
                              18
        undergo fission into platelets.  The morphologic similarities between   normal. These mice have increased numbers of small megakaryocytes
        platelets  that  form  new  cell  bodies  and  preplatelets  are  striking.   that exhibit an accelerated rate of proliferation. The small cytoplasmic
        Whether or not newly released platelets exhibit a preplatelet pheno-  volume  of  GATA1-deficient  megakaryocytes  typically  contains  an
        type, which allows them to form barbell-shapes and divide again, is   excess  of  rough  endoplasmic  reticulum,  very  few  platelet-specific
        not clear.                                            granules, and an underdeveloped or disorganized DMS, suggesting
                                                              that  maturation  of  megakaryocytes  is  arrested  in  GATA1-deficient
                                                              megakaryocytes.
        Location of Platelet Release                             A family with X-linked dyserythropoietic anemia and thrombo-
                                                              cytopenia  due  to  a  mutation  in  GATA1  has  been  described.  A
        Megakaryocytes are produced in the bone marrow, and some undergo   single-nucleotide  substitution  in  the  N-terminal  zinc  finger  of
        fragmentation into platelets in this location. It has been suggested   GATA1 inhibits the interaction of GATA1 with its essential cofactor,
        that,  by  extending  into  the  bone  marrow  sinusoids,  proplatelets   friend  of  GATA1  (FOG).  Although  megakaryocytes  in  affected
        provide a mechanism for extension into the bone, allowing release of   family members are abundant, they are unusually small and exhibit
        platelets directly into the circulation. 19,20  Megakaryocytes have been   several abnormal features, including an abundance of smooth endo-
        identified in intravascular sites within the lung, leading to a theory   plasmic reticulum, an underdeveloped DMS, and a lack of granules.
        that some platelets are formed from their parent cell in the pulmonary   These observations suggest an essential role for the FOG1-GATA1
        circulation.                                          interaction in thrombopoiesis. Genetic elimination of FOG in mice
                                                              unexpectedly  resulted  in  specific  ablation  of  the  megakaryocyte
                                                              lineage, suggesting a GATA1-independent role for FOG in the early
        Transcriptional Regulation of Platelet Formation      stages of megakaryocyte development; therefore GATA1 and FOG
                                                              are required for megakaryocyte generation from a common bipoten-
        Megakaryocyte development and platelet formation are controlled by   tial progenitor.
        the coordinated action of transcription factors that specifically turn   Several knockout mice also indicate a role for additional transcrip-
        on the genes of megakaryocyte precursors or suppress the expression   tion  factors  in  megakaryocyte  development.  Mice  carrying  a  null
                                      22
        of  genes  that  support  other  cell  types.   Gene-targeting  studies  in   mutation in Fli-1, a member of the ETS family of winged helix-turn-
        mice have identified several genes that are crucial for megakaryocyte   helix transcription factors that bind purine-rich sequences in gene
        development and platelet formation. Leading the list of transcription   promoters,  exhibit  defects  in  megakaryocyte  development.  Mega-
        factors that play an essential role in megakaryocyte maturation and   karyocytes cultured from mice lacking Fli-1 contain reduced numbers
        platelet  biogenesis  is  the  basic  leucine  zipper  heterodimer  NF-E2.   of α-granules, disorganization of the demarcation membranes, and a
        NF-E2 is a protein composed of a ubiquitously expressed 18–20-kDa   reduction in size. Mice lacking the hematopoietic zinc finger (Hzf)
        small-Maf subunit and a p45 subunit that is restricted to erythroid   protein,  a  transcription  factor  that  is  predominantly  expressed  in
        and megakaryocytic lineages. Although NF-E2 was postulated to be   megakaryocytes, have reduced numbers of α-granules in megakaryo-
        a transcription factor that specifically drove the expression of genes   cytes and platelets. Therefore Hzf may regulate the transcription of
        essential for erythropoiesis, mice lacking p45 NF-E2 do not exhibit   genes involved in the synthesis of α-granule components and/or their
        defects in erythropoiesis. Instead, mice deficient in the p45 subunit   packaging into α-granules. SCL, a basic helix-loop-helix transcrip-
        or two of the small-Maf subunits die of hemorrhage shortly after birth   tion factor initially identified in a subset of human T-cell leukemia
        because of a complete lack of circulating platelets. Although mega-  with multilineage characteristics, also appears to be critical for mega-
        karyocytes undergo normal endomitosis and proliferate in response   karyopoiesis. Results of deletion of SCL in mice indicate that this
        to TPO, mice deficient in p45 NF-E2 produce increased numbers of   transcription factor is required for proper erythroid and megakaryo-
        megakaryocytes that are larger than normal, contain fewer granules,   cyte development.
   2096   2097   2098   2099   2100   2101   2102   2103   2104   2105   2106